Leuprolide acetate, a GnRH agonist, improves experimental autoimmune encephalomyelitis: A possible therapy for multiple sclerosis

Neurochemical Research

Volumn 37, Issue 10, 2012, Pages 2190-2197

  Guzmán Soto, Irene ^a   Salinas, Eva ^a   Hernández Jasso, Irma ^a   Quintanar, J Luis ^a  

^a Autonomous University of Aguascalientes Centro de Ciencias Basicas   (Mexico)

Author keywords

Axon; Body weight; Myelin; Neuro regenerative; Neurofilaments; Neurotrophic factors

Indexed keywords

LEUPRORELIN; MYELIN BASIC PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG ACTIVITY; DRUG EFFICACY; FEMALE; MORPHOMETRICS; NEUROFILAMENT; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TREATMENT RESPONSE; WEIGHT GAIN;

ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GONADOTROPIN-RELEASING HORMONE; LEUPROLIDE; MULTIPLE SCLEROSIS; RATS; RATS, INBRED LEW;

ANIMALIA; RATTUS;

EID: 84866735171     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-012-0842-x     Document Type: Article

References (40)

1. Sospedra M, Martin R (2005) Immunology of multiple sclerosis. Annu Rev Immunol 23:683-747
2. O'Connor KC, Chitnis T, Griffin DE, Piyasirisilp S, Bar-Or A, Khoury S, Wucherpfennig KW, Hafler DA (2003) Myelin basic protein-reactive autoantibodies in the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by lowaffinity interactions. J Neuroimmunol 136:140-148
3. Sun D, Newman TA, Perry VH, Weller RO (2004) Cytokineinduced enhancement of autoimmune inflammation in the brain and spinal cord: implications for multiple sclerosis. Neuropathol Appl Neurobiol 30:374-384
4. Goverman J (2009) Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 9:393-407
5. Fugger L, Friese MA, Bell JI (2009) From genes to function: the next challenge to understanding multiple sclerosis. Nat Rev Immunol 9:408-417
6. Baxter AG (2007) The origin and application of experimental autoimmune encephalomyelitis. Nat Rev Immunol 7:904-912
7. Sullivan AM, Toulouse A (2011) Neurotrophic factors for the treatment of Parkinson's disease. Cytokine Growth Factor Rev 22:157-165
8. Thoenen H (1995) Neurotrophins and neuronal plasticity. Science 270:593-598
9. Barde YA (1997) Help from within for damaged axons. Nature 385:391-393
10. Moalem G, Gdalyahu A, Shani Y, Otten U, Lazarovici P, Cohen IR, Schwartz M (2000) Production of neurotrophins by activated T cells: implications for neuroprotective autoimmunity. J Autoimmun 15:331-345
11. Makar TK, Trisler D, Sura KT, Sultana S, Patel N, Bever CT (2008) Brain derived neurotrophic factor treatment reduces inflammation and apoptosis in experimental allergic encephalomyelitis. J Neurol Sci 270:70-76
12. Arnon R, Aharoni R (2009) Neuroprotection and neurogeneration in MS and its animal model EAE effected by glatiramer acetate. J Neural Transm 116:1443-1449
13. Lu Z, Hu X, Zhu C, Wang D, Zheng X, Liu Q (2009) Overexpression of CNTF in mesenchymal stem cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice. J Neuroimmunol 206: 58-69
14. Prange-Kiel J, Jarry H, Schoen M, Kohlmann P, Lohse C, Zhou L, Rune GM (2008) Gonadotropin-releasing hormone regulates spine density via its regulatory role in hippocampal estrogen synthesis. J Cell Biol 180:417-426
15. Quintanar JL, Salinas E (2008) Neurotrophic effects of GnRH on neurite outgrowth and neurofilament protein expression in cultured cerebral cortical neurons of rat embryos. Neurochem Res 33:1051-1056
16. Liu Q, Xie F, Alvarado-Diaz A, Smith MA, Moreira PI, Zhu X, Perry G (2011) Neurofilamentopathy in neurodegenerative diseases. Open Neurol J 5:58-62
17. Perrot R, Berges R, Bocquet A, Eyer J (2008) Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration. Mol Neurobiol 38:27-65
18. Quintanar JL, Salinas E, González R (2009) Gonadotropinreleasing hormone receptor in spinal cord neurons of embryos and adult rats. Neurosci Lett 461:21-24
19. Quintanar JL, Salinas E, Quintanar-Stephano A (2011) Gonadotropin- releasing hormone reduces the severity of experimental autoimmune encephalomyelitis, a model of multiple sclerosis. Neuropeptides 45:43-48
20. Wilson AC, Meethal SV, Bowen RL, Atwood CS (2007) Leuprolide acetate: a drug of diverse clinical applications. Expert Opin Investig Drugs 16:1851-1863
21. Fujino M, Fukuda T, Shinagawa S, Kobayashi S, Yamazaki I (1974) Synthetic analogs of luteinizing hormone releasing hormone (LH-RH) substituted in position 6 and 10. Biochem Biophys Res Commun 60:406-413
22. Abouelfadel Z, Crawford ED (2008) Leuprorelin depot injection: patient considerations in the management of prostatic cancer. Ther Clin Risk Manag 4:513-526
23. Wise PM (2002) Estrogens and neuroprotection. Trends Endocrinol Metab 13:229-230
24. Vadakkadath Meethal SV, Atwood CS (2005) The role of hypothalamic- pituitary-gonadal hormones in the normal structure and functioning of the brain. Cell Mol Life Sci 62:257-270
25. Quintanar-Stephano A, Chavira-Ramírez R, Kovacs K, Berczi I (2005) Neurointermediate pituitary lobectomy decreases the incidence and severity of experimental autoimmune encephalomyelitis in Lewis rats. J Endocrinol 184:51-58
26. Becher B, Durell BG, Miga AV, Hickey WF, Noelle RJ (2001) The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system. J Exp Med 193:967-974
27. Rossi S, Furlan R, De Chiara V, Motta C, Studer V, Mori F, Musella A, Bergami A, Muzio L, Bernardi G, Battistini L, Martino G, Centonze D (2012) Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis. Ann Neurol 71:76-83
28. Pollak Y, Orion E, Goshen I, Ovadia H, Yirmiya R (2002) Experimental autoimmune encephalomyelitis-associated behavioral syndrome as a model of 'depression due to multiple sclerosis'. Brain Behav Immun 16:533-543
29. Lou ZY, Chen C, He Q, Zhao CB, Xiao BG (2011) Targeting CB2 receptor as a neuroinflammatory modulator in experimental autoimmune encephalomyelitis. Mol Immunol 49:453-461
30. Vana AC, Li S, Ribeiro R, Tchantchou F, Zhang Y (2011) Arachidonyl trifluoromethyl ketone ameliorates experimental autoimmune encephalomyelitis via blocking peroxynitrite formation in mouse spinal cord white matter. Exp Neurol 231:45-55
31. Smith MR, Lee H, Fallon MA, Nathan DM (2008) Adipocytokines, obesity, and insulin resistance during combined androgen blockade for prostate cancer. Urology 71:318-322
32. Harris VK, Sadiq SA (2009) Disease biomarkers in multiple sclerosis, potential for use in therapeutic decision making. Mol Diagn Ther 13:225-244
33. Gresle MM, Butzkueven H, Shaw G (2011) Neurofilament proteins as body fluid biomarkers of neurodegeneration in multiple sclerosis. Mult Scler Int 2011:1-7
34. Vickers JC, King AE, Woodhouse A, Kirkcaldie MT, Staal JA, McCormack GH, Blizzard CA, Musgrove RE, Mitew S, Liu Y, Chuckowree JA, Bibari O, Dickson TC (2009) Axonopathy and cytoskeletal disruption in degenerative diseases of the central nervous system. Brain Res Bull 80:217-223
35. Avsar T, Korkmaz D, Tütüncü M, Demirci NO, Saip S, Kamasak M, Siva A, Turanli ET (2012) Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis. Mult Scler. doi:10.1177/ 1352458511433303
36. De Rosbo NK, Bernard CCA, Simmons RD, Carnegie PR (1985) Concomitant detection of changes in myelin basic protein and permeability of blood-spinal cord barrier in acute experimental autoimmune encephalomyelitis by electroimmunoblotting. J Neuroimmunol 9:349-361
37. Almolda B, Costa M, Montoya M, González B, Castellano B (2011) Increase in Th17 and T-reg lymphocytes and decrease of IL22 correlate with the recovery phase of acute EAE in rat. PLoS One 6:e27473
38. Mirowska-Guzel D (2009) The role of neurotrophic factors in the pathology and treatment of multiple sclerosis. Immunopharmacol Immunotoxicol 31:32-38
39. Kastin AJ, Coy DH, Schally AV, Zadina JE (1980) Dissociation of effects of LH-RH analogs on pituitary regulation and reproductive behavior. Pharmacol Biochem Behav 13:913-914
40. Barrera CM, Kastin AJ, Fasold MB, Banks WA (1991) Bidirectional saturable transport of LHRH across the blood-brain barrier. Am J Physiol 261:E312-E318